share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit

福泰製藥 | 4:持股變動聲明-高管 Sachdev Amit
美股sec公告 ·  06/07 16:14
Moomoo AI 已提取核心訊息
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.
Amit Sachdev,Vertex Pharmaceuticals Inc.(VRTX)首席患者及外部關係執行副總裁於2024年6月5日完成了一筆贈股交易,該交易涉及4600股普通股。由於這是一份真正的禮物,因此沒有費用發生。交易後,Sachdev在該公司的直接持股仍爲57290股。所出售的股份被置於信託中,表明這是一種間接的所有權形式。交易已完成,Sachdev現在事件後間接持有882股。
Amit Sachdev,Vertex Pharmaceuticals Inc.(VRTX)首席患者及外部關係執行副總裁於2024年6月5日完成了一筆贈股交易,該交易涉及4600股普通股。由於這是一份真正的禮物,因此沒有費用發生。交易後,Sachdev在該公司的直接持股仍爲57290股。所出售的股份被置於信託中,表明這是一種間接的所有權形式。交易已完成,Sachdev現在事件後間接持有882股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息